Last 12 months
Inside the activity.
0 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 09, 2026 Filed Mar 10, 2026 15:59 UTC |
RICKERTSEN CARL JDirector
|
GrantRestricted Stock Units · Derivative | 12,998 | $0.00 | $0.00 |
DisclosureSEC source: 0000041719-26-000034 · form4.xml · derivative · entry 1 RICKERTSEN CARL J · CIK 0001203479 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,998 Underlying: Common Stock, Par Value $.01 · 12,998 shares Expires 2027-03-09 F1 · derivative.exercise_price: Not applicable to this transaction. RSUs have no value until all restrictions lapse on the final vesting date. F2 · derivative.exercise_date: This 2026 Director grant vests in full and all restrictions lapse one year from the Grant Date. Read SEC document |
| March 09, 2026 Filed Mar 10, 2026 15:57 UTC |
Salmon TomDirector
|
GrantRestricted Stock Units · Derivative | 12,998 | $0.00 | $0.00 |
DisclosureSEC source: 0000041719-26-000032 · form4.xml · derivative · entry 1 Salmon Tom · CIK 0001559208 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,998 Underlying: Common Stock, Par Value $.01 · 12,998 shares Expires 2027-03-09 F1 · derivative.exercise_price: Not applicable to this transaction. RSUs have no value until all restrictions lapse on the final vesting date. F2 · derivative.exercise_date: This 2026 Director grant vests in full and all restrictions lapse one year from the Grant Date. Read SEC document |
| March 09, 2026 Filed Mar 10, 2026 15:54 UTC |
Marnick Samantha J.Director
|
GrantRestricted Stock Units · Derivative | 12,998 | $0.00 | $0.00 |
DisclosureSEC source: 0000041719-26-000030 · form4.xml · derivative · entry 1 Marnick Samantha J. · CIK 0001510064 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,998 Underlying: Common Stock, Par Value $.01 · 12,998 shares Expires 2027-03-09 F1 · derivative.exercise_price: Not applicable to this transaction. RSUs have no value until all restrictions lapse on the final vesting date. F2 · derivative.exercise_date: This 2026 Director grant vests in full and all restrictions lapse one year from the Grant Date. Read SEC document |
| March 09, 2026 Filed Mar 10, 2026 15:51 UTC |
Hall Mary DeanDirector
|
GrantRestricted Stock Units · Derivative | 12,998 | $0.00 | $0.00 |
DisclosureSEC source: 0000041719-26-000028 · form4.xml · derivative · entry 1 Hall Mary Dean · CIK 0001659705 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,998 Underlying: Common Stock, Par Value $.01 · 12,998 shares Expires 2027-03-09 F1 · derivative.exercise_price: Not applicable to this transaction. RSUs have no value until all restrictions lapse on the final vesting date. F2 · derivative.exercise_date: This 2026 Director grant vests in full and all restrictions lapse one year from the Grant Date. Read SEC document |
| March 09, 2026 Filed Mar 10, 2026 15:45 UTC |
Curless Michael SDirector
|
GrantRestricted Stock Units · Derivative | 12,998 | $0.00 | $0.00 |
DisclosureSEC source: 0000041719-26-000026 · form4.xml · derivative · entry 1 Curless Michael S · CIK 0001580949 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,998 Underlying: Common Stock, Par Value $.01 · 12,998 shares Expires 2027-03-09 F1 · derivative.exercise_price: Not applicable to this transaction. RSUs have no value until all restrictions lapse on the final vesting date. F2 · derivative.exercise_date: This 2026 Director grant vests in full and all restrictions lapse one year from the Grant Date. Read SEC document |
| March 09, 2026 Filed Mar 10, 2026 15:37 UTC |
Fogarty Kevin MichaelDirector
|
GrantRestricted Stock Units · Derivative | 12,998 | $0.00 | $0.00 |
DisclosureSEC source: 0000041719-26-000024 · form4.xml · derivative · entry 1 Fogarty Kevin Michael · CIK 0001478560 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,998 Underlying: Common Stock, Par Value $.01 · 12,998 shares Expires 2027-03-09 F1 · derivative.exercise_price: Not applicable to this transaction. RSUs have no value until all restrictions lapse on the final vesting date. F2 · derivative.exercise_date: This 2026 Director grant vests in full and all restrictions lapse one year from the Grant Date. Read SEC document |
| March 09, 2026 Filed Mar 10, 2026 15:35 UTC |
Fahnemann ThomasDirector
|
GrantRestricted Stock Units · Derivative | 12,998 | $0.00 | $0.00 |
DisclosureSEC source: 0000041719-26-000022 · form4.xml · derivative · entry 1 Fahnemann Thomas · CIK 0001943784 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,998 Underlying: Common Stock, Par Value $.01 · 12,998 shares Expires 2027-03-09 F1 · derivative.exercise_price: Not applicable to this transaction. RSUs have no value until all restrictions lapse on the final vesting date. F2 · derivative.exercise_date: This 2026 Director grant vests in full and all restrictions lapse one year from the Grant Date. Read SEC document |
| March 09, 2026 Filed Mar 10, 2026 15:31 UTC |
Brown BruceDirector
|
GrantRestricted Stock Units · Derivative | 12,998 | $0.00 | $0.00 |
DisclosureSEC source: 0000041719-26-000020 · form4.xml · derivative · entry 1 Brown Bruce · CIK 0001436840 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,998 Underlying: Common Stock, Par Value $.01 · 12,998 shares Expires 2027-03-09 F1 · derivative.exercise_price: Not applicable to this transaction. RSUs have no value until all restrictions lapse on the final vesting date. F2 · derivative.exercise_date: This 2026 Director grant vests in full and all restrictions lapse one year from the Grant Date. Read SEC document |
| February 28, 2026 Filed Mar 3, 2026 16:51 UTC |
Urey Jill L.EVP, GC & Corp Sec
|
Exercise / conversionRestricted Stock Units · Derivative | 1,571 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000041719-26-000018 · form4.xml · derivative · entry 3 Urey Jill L. · CIK 0001789456 · EVP, GC & Corp Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,620 Underlying: Common Stock, Par Value $.01 · 1,571 shares Expires 2027-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Not applicable to this transaction. RSUs have no value until all restrictions lapse on the final vesting date. F4 · derivative.expiration_date: Represents the 2024 RSU LTIP grant, which vests one-third 12/31/2024, one-third 2/28/2026 and one-third 2/28/2027. Read SEC document |
| February 28, 2026 Filed Mar 3, 2026 16:51 UTC |
Urey Jill L.EVP, GC & Corp Sec
|
Tax withholdingCommon Stock, Par Value $.01 | 521 | $12.95 | $6,746.95 |
DisclosureSEC source: 0000041719-26-000018 · form4.xml · nonDerivative · entry 2 Urey Jill L. · CIK 0001789456 · EVP, GC & Corp Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,134 F2 · shares: Represents shares being withheld to satisfy tax obligations. F1 · price: Because the award lapsed on Saturday, February 28, 2026, the value of the shares was determined using the closing price of the previous business day, Friday, February 27, 2026. Read SEC document |
| February 28, 2026 Filed Mar 3, 2026 16:51 UTC |
Urey Jill L.EVP, GC & Corp Sec
|
Exercise / conversionCommon Stock, Par Value $.01 | 1,571 | $12.95 | $20,344.45 |
DisclosureSEC source: 0000041719-26-000018 · form4.xml · nonDerivative · entry 1 Urey Jill L. · CIK 0001789456 · EVP, GC & Corp Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,655 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Because the award lapsed on Saturday, February 28, 2026, the value of the shares was determined using the closing price of the previous business day, Friday, February 27, 2026. Read SEC document |
| February 24, 2026 Filed Feb 26, 2026 16:41 UTC |
Urey Jill L.EVP, GC & Corp Sec
|
Exercise / conversionRestricted Stock Units · Derivative | 205 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000041719-26-000016 · form4.xml · derivative · entry 3 Urey Jill L. · CIK 0001789456 · EVP, GC & Corp Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, Par Value $.01 · 205 shares Expires 2026-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Not applicable to this transaction. RSUs have no value until all restrictions lapse on the final vesting date. F2 · derivative.exercise_date: This 2023 RSU LTIP grant vests one-third 02/24/2024, one-third 02/24/2025 and one-third 02/24/2026. Read SEC document |
| February 24, 2026 Filed Feb 26, 2026 16:41 UTC |
Urey Jill L.EVP, GC & Corp Sec
|
Tax withholdingCommon Stock, Par Value $.01 | 68 | $13.03 | $886.04 |
DisclosureSEC source: 0000041719-26-000016 · form4.xml · nonDerivative · entry 2 Urey Jill L. · CIK 0001789456 · EVP, GC & Corp Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,084 Read SEC document |
| February 24, 2026 Filed Feb 26, 2026 16:41 UTC |
Urey Jill L.EVP, GC & Corp Sec
|
Exercise / conversionCommon Stock, Par Value $.01 | 205 | $13.03 | $2,671.15 |
DisclosureSEC source: 0000041719-26-000016 · form4.xml · nonDerivative · entry 1 Urey Jill L. · CIK 0001789456 · EVP, GC & Corp Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,152 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 14, 2025 Filed Nov 18, 2025 21:39 UTC |
Fogarty Kevin MichaelDirector
|
GrantRestricted Stock Units · Derivative | 5,871 | $0.00 | $0.00 |
DisclosureSEC source: 0000041719-25-000102 · form4.xml · derivative · entry 1 Fogarty Kevin Michael · CIK 0001478560 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,871 Underlying: Common Stock, Par Value $.01 · 5,871 shares Expires 2026-11-14 F1 · derivative.exercise_price: Not applicable to this transaction. RSUs have no value until all restrictions lapse on the final vesting date. F2 · shares: To align the director equity schedule with the Annual Shareholders Meeting moving forward, this grant represents a prorated value of the Annual Director Award for the period between the 2024 RSU lapse reported on November 4, 2025 and the Annual Shareholder Meeting in 2026, at which time directors will be granted a full 2026 Annual Director Award upon their reelection. F3 · derivative.exercise_date: This 2025 Prorated Director Award vests in full one year from the grant date. Read SEC document |
| November 14, 2025 Filed Nov 18, 2025 21:41 UTC |
Brown BruceDirector
|
GrantRestricted Stock Units · Derivative | 5,871 | $0.00 | $0.00 |
DisclosureSEC source: 0000041719-25-000104 · form4.xml · derivative · entry 1 Brown Bruce · CIK 0001436840 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,871 Underlying: Common Stock, Par Value $.01 · 5,871 shares Expires 2026-11-14 F1 · derivative.exercise_price: Not applicable to this transaction. RSUs have no value until all restrictions lapse on the final vesting date. F2 · shares: To align the director equity schedule with the Annual Shareholders Meeting moving forward, this grant represents a prorated value of the Annual Director Award for the period between the 2024 RSU lapse reported on November 4, 2025 and the Annual Shareholder Meeting in 2026, at which time directors will be granted a full 2026 Annual Director Award upon their reelection. F3 · derivative.exercise_date: This 2025 Prorated Director Award vests in full one year from the grant date. Read SEC document |
| November 14, 2025 Filed Nov 18, 2025 21:33 UTC |
Fahnemann ThomasDirector
|
GrantRestricted Stock Units · Derivative | 5,871 | $0.00 | $0.00 |
DisclosureSEC source: 0000041719-25-000098 · form4.xml · derivative · entry 1 Fahnemann Thomas · CIK 0001943784 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,871 Underlying: Common Stock, Par Value $.01 · 5,871 shares Expires 2026-11-14 F1 · derivative.exercise_price: Not applicable to this transaction. RSUs have no value until all restrictions lapse on the final vesting date. F2 · shares: To align the director equity schedule with the Annual Shareholders Meeting moving forward, this grant represents a prorated value of the Annual Director Award for the period between the 2024 RSU lapse reported on November 4, 2025 and the Annual Shareholder Meeting in 2026, at which time directors will be granted a full 2026 Annual Director Award upon their reelection. F3 · derivative.exercise_date: This 2025 Prorated Director Award vests in full one year from the grant date. Read SEC document |
| November 14, 2025 Filed Nov 18, 2025 21:35 UTC |
Curless Michael SDirector
|
GrantRestricted Stock Units · Derivative | 5,871 | $0.00 | $0.00 |
DisclosureSEC source: 0000041719-25-000100 · form4.xml · derivative · entry 1 Curless Michael S · CIK 0001580949 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,871 Underlying: Common Stock, Par Value $.01 · 5,871 shares Expires 2026-11-14 F1 · derivative.exercise_price: Not applicable to this transaction. RSUs have no value until all restrictions lapse on the final vesting date. F2 · shares: To align the director equity schedule with the Annual Shareholders Meeting moving forward, this grant represents a prorated value of the Annual Director Award for the period between the 2024 RSU lapse reported on November 4, 2025 and the Annual Shareholder Meeting in 2026, at which time directors will be granted a full 2026 Annual Director Award upon their reelection. F3 · derivative.exercise_date: This 2025 Prorated Director Award vests in full one year from the grant date. Read SEC document |
| November 14, 2025 Filed Nov 18, 2025 21:28 UTC |
Salmon TomDirector
|
GrantRestricted Stock Units · Derivative | 5,871 | $0.00 | $0.00 |
DisclosureSEC source: 0000041719-25-000096 · form4.xml · derivative · entry 1 Salmon Tom · CIK 0001559208 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,871 Underlying: Common Stock, Par Value $.01 · 5,871 shares Expires 2026-11-14 F1 · derivative.exercise_price: Not applicable to this transaction. RSUs have no value until all restrictions lapse on the final vesting date. F2 · shares: To align the director equity schedule with the Annual Shareholders Meeting moving forward, this grant represents a prorated value of the Annual Director Award for the period between the 2024 RSU lapse reported on November 4, 2025 and the Annual Shareholder Meeting in 2026, at which time directors will be granted a full 2026 Annual Director Award upon their reelection. F3 · derivative.exercise_date: This 2025 Prorated Director Award vests in full one year from the grant date. Read SEC document |
| November 14, 2025 Filed Nov 18, 2025 21:24 UTC |
Marnick Samantha J.Director
|
GrantRestricted Stock Units · Derivative | 5,871 | $0.00 | $0.00 |
DisclosureSEC source: 0000041719-25-000092 · form4.xml · derivative · entry 1 Marnick Samantha J. · CIK 0001510064 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,871 Underlying: Common Stock, Par Value $.01 · 5,871 shares Expires 2026-11-14 F1 · derivative.exercise_price: Not applicable to this transaction. RSUs have no value until all restrictions lapse on the final vesting date. F2 · shares: To align the director equity schedule with the Annual Shareholders Meeting moving forward, this grant represents a prorated value of the Annual Director Award for the period between the 2024 RSU lapse reported on November 4, 2025 and the Annual Shareholder Meeting in 2026, at which time directors will be granted a full 2026 Annual Director Award upon their reelection. F3 · derivative.exercise_date: This 2025 Prorated Director Award vests in full one year from the grant date. Read SEC document |
| November 14, 2025 Filed Nov 18, 2025 21:26 UTC |
RICKERTSEN CARL JDirector
|
GrantRestricted Stock Units · Derivative | 5,871 | $0.00 | $0.00 |
DisclosureSEC source: 0000041719-25-000094 · form4.xml · derivative · entry 1 RICKERTSEN CARL J · CIK 0001203479 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,871 Underlying: Common Stock, Par Value $.01 · 5,871 shares Expires 2026-11-14 F1 · derivative.exercise_price: Not applicable to this transaction. RSUs have no value until all restrictions lapse on the final vesting date. F2 · shares: To align the director equity schedule with the Annual Shareholders Meeting moving forward, this grant represents a prorated value of the Annual Director Award for the period between the 2024 RSU lapse reported on November 4, 2025 and the Annual Shareholder Meeting in 2026, at which time directors will be granted a full 2026 Annual Director Award upon their reelection. F3 · derivative.exercise_date: This 2025 Prorated Director Award vests in full one year from the grant date. Read SEC document |
| November 14, 2025 Filed Nov 18, 2025 15:27 UTC |
Begle CurtDirector · President & CEO
|
GrantRestricted Stock Units · Derivative | 131,428 | $0.00 | $0.00 |
DisclosureSEC source: 0000041719-25-000088 · form4.xml · derivative · entry 1 Begle Curt · CIK 0001559276 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 131,428 Underlying: Common Stock, Par Value $.01 · 131,428 shares Expires 2028-11-14 F1 · derivative.exercise_price: Not applicable to this transaction. RSUs have no value until all restrictions lapse on the final vesting date. F2 · derivative.exercise_date: Represents the FY2026 Annual RSU grant, which vests one-third 11/14/2026, one-third 11/14/2027 and one-third 11/14/2028. F3 · derivative.expiration_date: This grant vests in full, and all restrictions lapse, three years from the Grant Date. Read SEC document |
| November 14, 2025 Filed Nov 18, 2025 21:22 UTC |
Hall Mary DeanDirector
|
GrantRestricted Stock Units · Derivative | 5,871 | $0.00 | $0.00 |
DisclosureSEC source: 0000041719-25-000090 · form4.xml · derivative · entry 1 Hall Mary Dean · CIK 0001659705 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,871 Underlying: Common Stock, Par Value $.01 · 5,871 shares Expires 2026-11-14 F1 · derivative.exercise_price: Not applicable to this transaction. RSUs have no value until all restrictions lapse on the final vesting date. F2 · shares: To align the director equity schedule with the Annual Shareholders Meeting moving forward, this grant represents a prorated value of the Annual Director Award for the period between the 2024 RSU lapse reported on November 4, 2025 and the Annual Shareholder Meeting in 2026, at which time directors will be granted a full 2026 Annual Director Award upon their reelection. F3 · derivative.exercise_date: This 2025 Prorated Director Award vests in full one year from the grant date. Read SEC document |
| November 14, 2025 Filed Nov 18, 2025 15:14 UTC |
Till JamesEVP, CFO & Treasurer
|
GrantRestricted Stock Units · Derivative | 34,285 | $0.00 | $0.00 |
DisclosureSEC source: 0000041719-25-000086 · form4.xml · derivative · entry 1 Till James · CIK 0001596705 · EVP, CFO & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,285 Underlying: Common Stock, Par Value $.01 · 34,285 shares Expires 2028-11-14 F1 · derivative.exercise_price: Not applicable to this transaction. RSUs have no value until all restrictions lapse on the final vesting date. F2 · derivative.exercise_date: Represents the FY2026 Annual RSU grant, which vests one-third 11/14/2026, one-third 11/14/2027 and one-third 11/14/2028. F3 · derivative.expiration_date: This grant vests in full, and all restrictions lapse, three years from the Grant Date. Read SEC document |
| November 14, 2025 Filed Nov 18, 2025 14:56 UTC |
Urey Jill L.EVP, GC & Corp Sec
|
GrantRestricted Stock Units · Derivative | 14,285 | $0.00 | $0.00 |
DisclosureSEC source: 0000041719-25-000082 · form4.xml · derivative · entry 1 Urey Jill L. · CIK 0001789456 · EVP, GC & Corp Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,285 Underlying: Common Stock, Par Value $.01 · 14,285 shares Expires 2028-11-14 F1 · derivative.exercise_price: Not applicable to this transaction. RSUs have no value until all restrictions lapse on the final vesting date. F2 · derivative.exercise_date: Represents the FY2026 Annual RSU grant, which vests one-third 11/14/2026, one-third 11/14/2027 and one-third 11/14/2028. F3 · derivative.expiration_date: This grant vests in full, and all restrictions lapse, three years from the Grant Date. Read SEC document |
| November 14, 2025 Filed Nov 18, 2025 15:09 UTC |
Manroa TarunEVP, COO
|
GrantRestricted Stock Units · Derivative | 34,285 | $0.00 | $0.00 |
DisclosureSEC source: 0000041719-25-000084 · form4.xml · derivative · entry 1 Manroa Tarun · CIK 0002042335 · EVP, COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,285 Underlying: Common Stock, Par Value $.01 · 34,285 shares Expires 2028-11-14 F1 · derivative.exercise_price: Not applicable to this transaction. RSUs have no value until all restrictions lapse on the final vesting date. F2 · derivative.exercise_date: Represents the FY2026 Annual RSU grant, which vests one-third 11/14/2026, one-third 11/14/2027 and one-third 11/14/2028. F3 · derivative.expiration_date: This grant vests in full, and all restrictions lapse, three years from the Grant Date. Read SEC document |
| November 04, 2025 Filed Nov 6, 2025 21:04 UTC |
Begle CurtDirector · President & CEO
|
Exercise / conversionRestricted Stock Units · Derivative | 18,208 | $0.00 | $0.00 |
DisclosureSEC source: 0000041719-25-000077 · form4.xml · derivative · entry 5 Begle Curt · CIK 0001559276 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,423 Underlying: Common Stock, Par Value $.01 · 18,208 shares Expires 2027-11-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Not applicable to this transaction. RSUs have no value until all restrictions lapse on the final vesting date. F5 · derivative.exercise_date: This FY2025 Annual RSU grant vests one-third 11/4/2025, one-third 11/4/2026 and one-third 11/4/2027. This grant vests in full, and all restrictions lapse, three years from the Grant Date. Read SEC document |
| November 04, 2025 Filed Nov 6, 2025 21:04 UTC |
Begle CurtDirector · President & CEO
|
Exercise / conversionCommon Stock, Par Value $.01 | 18,208 | $8.53 | $155,314.24 |
DisclosureSEC source: 0000041719-25-000077 · form4.xml · nonDerivative · entry 1 Begle Curt · CIK 0001559276 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,208 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 04, 2025 Filed Nov 6, 2025 21:00 UTC |
Till JamesEVP, CFO & Treasurer
|
Exercise / conversionRestricted Stock Units · Derivative | 4,749 | $0.00 | $0.00 |
DisclosureSEC source: 0000041719-25-000075 · form4.xml · derivative · entry 3 Till James · CIK 0001596705 · EVP, CFO & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,502 Underlying: Common Stock, Par Value $.01 · 4,749 shares Expires 2027-11-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Not applicable to this transaction. RSUs have no value until all restrictions lapse on the final vesting date. F3 · derivative.exercise_date: This FY2025 Annual RSU grant vests one-third 11/4/2025, one-third 11/4/2026 and one-third 11/4/2027. This grant vests in full, and all restrictions lapse, three years from the Grant Date. Read SEC document |
| November 04, 2025 Filed Nov 6, 2025 21:00 UTC |
Till JamesEVP, CFO & Treasurer
|
Tax withholdingCommon Stock, Par Value $.01 | 2,023 | $8.53 | $17,256.19 |
DisclosureSEC source: 0000041719-25-000075 · form4.xml · nonDerivative · entry 2 Till James · CIK 0001596705 · EVP, CFO & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,726 F1 · shares: Represents shares being withheld to satisfy tax obligations. Read SEC document |
| November 04, 2025 Filed Nov 6, 2025 21:00 UTC |
Till JamesEVP, CFO & Treasurer
|
Exercise / conversionCommon Stock, Par Value $.01 | 4,749 | $8.53 | $40,508.97 |
DisclosureSEC source: 0000041719-25-000075 · form4.xml · nonDerivative · entry 1 Till James · CIK 0001596705 · EVP, CFO & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,749 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 04, 2025 Filed Nov 6, 2025 20:56 UTC |
Manroa TarunEVP, COO
|
Exercise / conversionRestricted Stock Units · Derivative | 3,562 | $0.00 | $0.00 |
DisclosureSEC source: 0000041719-25-000073 · form4.xml · derivative · entry 3 Manroa Tarun · CIK 0002042335 · EVP, COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,126 Underlying: Common Stock, Par Value $.01 · 3,562 shares Expires 2027-11-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Not applicable to this transaction. RSUs have no value until all restrictions lapse on the final vesting date. F3 · derivative.exercise_date: This FY2025 Annual RSU grant vests one-third 11/4/2025, one-third 11/4/2026 and one-third 11/4/2027. This grant vests in full, and all restrictions lapse, three years from the Grant Date. Read SEC document |
| November 04, 2025 Filed Nov 6, 2025 20:56 UTC |
Manroa TarunEVP, COO
|
Tax withholdingCommon Stock, Par Value $.01 | 1,580 | $8.53 | $13,477.40 |
DisclosureSEC source: 0000041719-25-000073 · form4.xml · nonDerivative · entry 2 Manroa Tarun · CIK 0002042335 · EVP, COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,015 F1 · shares: Represents shares being withheld to satisfy tax obligations. Read SEC document |
| November 04, 2025 Filed Nov 6, 2025 20:56 UTC |
Manroa TarunEVP, COO
|
Exercise / conversionCommon Stock, Par Value $.01 | 3,562 | $8.53 | $30,383.86 |
DisclosureSEC source: 0000041719-25-000073 · form4.xml · nonDerivative · entry 1 Manroa Tarun · CIK 0002042335 · EVP, COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,595 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 04, 2025 Filed Nov 6, 2025 20:48 UTC |
Urey Jill L.EVP, GC & Corp Sec
|
Exercise / conversionRestricted Stock Units · Derivative | 1,583 | $0.00 | $0.00 |
DisclosureSEC source: 0000041719-25-000071 · form4.xml · derivative · entry 4 Urey Jill L. · CIK 0001789456 · EVP, GC & Corp Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,167 Underlying: Common Stock, Par Value $.01 · 1,583 shares Expires 2027-11-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Not applicable to this transaction. RSUs have no value until all restrictions lapse on the final vesting date. F3 · derivative.exercise_date: This FY2025 Annual RSU grant vests one-third 11/4/2025, one-third 11/4/2026 and one-third 11/4/2027. This grant vests in full, and all restrictions lapse, three years from the Grant Date. Read SEC document |
| November 04, 2025 Filed Nov 6, 2025 20:48 UTC |
Urey Jill L.EVP, GC & Corp Sec
|
Tax withholdingCommon Stock, Par Value $.01 | 441 | $8.53 | $3,761.73 |
DisclosureSEC source: 0000041719-25-000071 · form4.xml · nonDerivative · entry 2 Urey Jill L. · CIK 0001789456 · EVP, GC & Corp Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,947 F1 · shares: Represents shares being withheld to satisfy tax obligations. Read SEC document |
| November 04, 2025 Filed Nov 6, 2025 20:48 UTC |
Urey Jill L.EVP, GC & Corp Sec
|
Exercise / conversionCommon Stock, Par Value $.01 | 1,583 | $8.53 | $13,502.99 |
DisclosureSEC source: 0000041719-25-000071 · form4.xml · nonDerivative · entry 1 Urey Jill L. · CIK 0001789456 · EVP, GC & Corp Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,388 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 04, 2025 Filed Nov 6, 2025 20:39 UTC |
Fahnemann ThomasDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 7,125 | $0.00 | $0.00 |
DisclosureSEC source: 0000041719-25-000068 · form4.xml · derivative · entry 2 Fahnemann Thomas · CIK 0001943784 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, Par Value $.01 · 7,125 shares Expires 2025-11-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Not applicable to this transaction. RSUs have no value until all restrictions lapse on the final vesting date. F2 · derivative.exercise_date: This FY2025 Director grant vests in full and all restrictions lapse one year from the Grant Date. Read SEC document |
| November 04, 2025 Filed Nov 6, 2025 20:39 UTC |
Fahnemann ThomasDirector
|
Exercise / conversionCommon Stock, Par Value $.01 | 7,125 | $8.53 | $60,776.25 |
DisclosureSEC source: 0000041719-25-000068 · form4.xml · nonDerivative · entry 1 Fahnemann Thomas · CIK 0001943784 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 83,622 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 04, 2025 Filed Nov 6, 2025 20:41 UTC |
Marnick Samantha J.Director
|
Exercise / conversionRestricted Stock Units · Derivative | 9,501 | $0.00 | $0.00 |
DisclosureSEC source: 0000041719-25-000070 · form4.xml · derivative · entry 2 Marnick Samantha J. · CIK 0001510064 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, Par Value $.01 · 9,501 shares Expires 2025-11-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Not applicable to this transaction. RSUs have no value until all restrictions lapse on the final vesting date. F2 · derivative.exercise_date: This FY2025 Director grant vests in full and all restrictions lapse one year from the Grant Date. Read SEC document |
| November 04, 2025 Filed Nov 6, 2025 20:41 UTC |
Marnick Samantha J.Director
|
Exercise / conversionCommon Stock, Par Value $.01 | 9,501 | $8.53 | $81,043.53 |
DisclosureSEC source: 0000041719-25-000070 · form4.xml · nonDerivative · entry 1 Marnick Samantha J. · CIK 0001510064 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,501 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 04, 2025 Filed Nov 6, 2025 20:28 UTC |
Fogarty Kevin MichaelDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 9,501 | $0.00 | $0.00 |
DisclosureSEC source: 0000041719-25-000061 · form4.xml · derivative · entry 3 Fogarty Kevin Michael · CIK 0001478560 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, Par Value $.01 · 9,501 shares Expires 2025-11-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Not applicable to this transaction. RSUs have no value until all restrictions lapse on the final vesting date. F2 · derivative.exercise_date: This FY2025 Director grant vests in full and all restrictions lapse one year from the Grant Date. Read SEC document |
| November 04, 2025 Filed Nov 6, 2025 20:28 UTC |
Fogarty Kevin MichaelDirector
|
Exercise / conversionCommon Stock, Par Value $.01 | 9,501 | $8.53 | $81,043.53 |
DisclosureSEC source: 0000041719-25-000061 · form4.xml · nonDerivative · entry 1 Fogarty Kevin Michael · CIK 0001478560 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,314 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 04, 2025 Filed Nov 6, 2025 20:37 UTC |
RICKERTSEN CARL JDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 9,501 | $0.00 | $0.00 |
DisclosureSEC source: 0000041719-25-000066 · form4.xml · derivative · entry 2 RICKERTSEN CARL J · CIK 0001203479 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, Par Value $.01 · 9,501 shares Expires 2025-11-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Not applicable to this transaction. RSUs have no value until all restrictions lapse on the final vesting date. F2 · derivative.exercise_date: This FY2025 Director grant vests in full and all restrictions lapse one year from the Grant Date. Read SEC document |
| November 04, 2025 Filed Nov 6, 2025 20:37 UTC |
RICKERTSEN CARL JDirector
|
Exercise / conversionCommon Stock, Par Value $.01 | 9,501 | $8.53 | $81,043.53 |
DisclosureSEC source: 0000041719-25-000066 · form4.xml · nonDerivative · entry 1 RICKERTSEN CARL J · CIK 0001203479 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,807 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 04, 2025 Filed Nov 6, 2025 20:33 UTC |
Hall Mary DeanDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 9,501 | $0.00 | $0.00 |
DisclosureSEC source: 0000041719-25-000064 · form4.xml · derivative · entry 2 Hall Mary Dean · CIK 0001659705 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, Par Value $.01 · 9,501 shares Expires 2025-11-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Not applicable to this transaction. RSUs have no value until all restrictions lapse on the final vesting date. F2 · derivative.exercise_date: This FY2025 Director grant vests in full and all restrictions lapse one year from the Grant Date. Read SEC document |
| November 04, 2025 Filed Nov 6, 2025 20:33 UTC |
Hall Mary DeanDirector
|
Exercise / conversionCommon Stock, Par Value $.01 | 9,501 | $8.53 | $81,043.53 |
DisclosureSEC source: 0000041719-25-000064 · form4.xml · nonDerivative · entry 1 Hall Mary Dean · CIK 0001659705 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,501 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 04, 2025 Filed Nov 6, 2025 20:23 UTC |
Curless Michael SDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 9,501 | $0.00 | $0.00 |
DisclosureSEC source: 0000041719-25-000059 · form4.xml · derivative · entry 3 Curless Michael S · CIK 0001580949 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, Par Value $.01 · 9,501 shares Expires 2025-11-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Not applicable to this transaction. RSUs have no value until all restrictions lapse on the final vesting date. F3 · derivative.exercise_date: This FY2025 Director grant vests in full and all restrictions lapse one year from the Grant Date. Read SEC document |
| November 04, 2025 Filed Nov 6, 2025 20:23 UTC |
Curless Michael SDirector
|
Exercise / conversionCommon Stock, Par Value $.01 | 9,501 | $8.53 | $81,043.53 |
DisclosureSEC source: 0000041719-25-000059 · form4.xml · nonDerivative · entry 1 Curless Michael S · CIK 0001580949 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,501 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 04, 2025 Filed Nov 6, 2025 20:19 UTC |
Salmon TomDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 9,501 | $0.00 | $0.00 |
DisclosureSEC source: 0000041719-25-000057 · form4.xml · derivative · entry 3 Salmon Tom · CIK 0001559208 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, Par Value $.01 · 9,501 shares Expires 2025-11-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Not applicable to this transaction. RSUs have no value until all restrictions lapse on the final vesting date. F3 · derivative.exercise_date: This FY2025 Director grant vests in full and all restrictions lapse one year from the Grant Date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.